menu search

Regeneron, sanofi withdraw fda application for libtayo's expanded use

Regeneron Pharmaceuticals Inc  REGN and its partner Sanofi SA SNY have voluntarily withdrawn their application with the FDA for the expanded use ...

January 28, 2022, 10:31 am

Regeneron, sanofi withdraw application for libtaya as a cervical cancer treatment in the u.s.

Shares of Regeneron Pharmaceuticals Inc. REGN, +0.57% were down 0.1% in premarket trading on Friday after the company and Sanofi SNY, +3.00% said they...

January 28, 2022, 7:32 am

Regeneron, sanofi withdraw application for libtaya as a cervical cancer treatment in the u.s.

Shares of Regeneron Pharmaceuticals Inc. REGN, +0.57% were down 0.1% in premarket trading on Friday after the company and Sanofi SNY, +3.00% said they...

January 28, 2022, 7:32 am

Regeneron, sanofi withdraw application for libtaya as a cervical cancer treatment in the u.s.

Shares of Regeneron Pharmaceuticals Inc. REGN, +0.57% were down 0.1% in premarket trading on Friday after the company and Sanofi SNY, +3.00% said they...

January 28, 2022, 7:32 am


Search within

Pages Search Results: